 |
||||||||||||||||||||
|
|
A genomics-based pharmaceutical company dedicated to improving the lives of people by developing novel protein, antibody, and small molecule therapeutics in the areas of oncology, inflammation, obesity, diabetes, and central nervous system disorders is interested in receiving information on UTHSC-Houston technologies. The companies therapeutics are based on genes that are believed to play a role in important mechanisms underlying disease, including cell proliferation, anti-angiogenesis and peripheral metabolism. The company is accepting in-house licensing opportunities in the field of life sciences and genomics. The company would like to receive non-confidential disclosures of technologies for which UTHSC-Houston is seeking patent protection. Please contact the Office of Technology Management if you have any technology that may be relevant to this request. |
|||||||||||||||||||
